PolicyBot
Search our database by keyword or with the filters below.
Search Results
220 items
August 19, 2019
The Trump administration is working to permit the importation of less-expensive prescription drugs originally intended for foreign markets.
July 11, 2019
As the 2020 election creeps closer, candidates are focusing increasingly more on solving one of the most vexing problems Americans regularly encounter: the incredibly high cost of prescription drugs.
March 7, 2019
ALSO: 95% of Voters Believe Patients and Doctors, not Bureaucrats, Should Be Most Responsible for Treatment Decisions
May 22, 2018
"Now, at long last, American patients and their families can have hope that a life-saving drug will no longer be denied to them because of bureaucratic barriers." -- Dr. Tim Huelskamp
May 18, 2017
In a letter signed by The Heartland Institute, the authors argue drug importation would ultimately harm patients.
March 1, 2005
Anyone who watches television or reads popular magazines knows the amount of money spent on advertising for prescription drugs has increased dramatically in the past few years.
February 1, 2005
An end-of-year Associated Press poll showed that, despite recent product withdrawals and reported health risks of popular medicines, U.S. consumer confidence in the safety of prescription drugs remains high.
April 1, 2002
State elected officials across the country, hard-pressed to keep expensive promises they made during the good economic times of the 1990s, are considering legislation that would force drug manufacturers to pay “supplemental rebates”to have their drugs
August 1, 2007
The following is an excerpt from the booklet More Choices, Better Health: Free to Choose Experimental Drugs, by Bartley J. Madden--the third in a several-part series. The complete booklet is also available online at http://www.heartland.org/Article.cfm?
December 5, 2006
(Chicago, Illinois - December 5, 2006) The U.S. Government Accountability Office is expected to release a study on direct-to-consumer advertising (DTC) of prescription drugs in the coming weeks.
December 1, 2004
Ten years ago, the multinational pharmaceutical company AstraZeneca launched what was known inside the company as the Shark Fin Project.
September 1, 2004
In July, the U.S. House and Senate passed and sent to the president the U.S.-Australia Free Trade Agreement.
March 15, 2022
In this Research & Commentary Matt Dean looks at new compassionate care access that picks up where right to try left off
April 13, 2020
The so-call "Purple Book" is a list of all licensed biologic products and is a reference guide for patients, providers, payers and manufactureres.
April 2, 2020
America is completely dependent on China and India for its pharmaceutical drug supply.
December 17, 2019
The U.S. Senate considers the nomination of Stephen Hahn to head the FDA.
December 5, 2019
Parmacogenetic testing is a new field in prescription medicine.
May 28, 2019
The biosimilar drug industry, along with consumer, taxpayer and health care groups are crying foul over the Food and Drug Administration’s newly released guidelines requiring a four-letter suffix on biosimilar drug names that would distinguish them from t
November 20, 2018
The U.S. Food and Drug Administration (FDA) approved a record number of generic drugs in fiscal year 2018.
July 26, 2017
The federal agency has published the list to enhance competition.
Page
of
11
›
